- Home
- INDO vs RNXT Comparison
INDO vs RNXT Comparison
Compare INDO & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDO
- RNXT
- Stock Information
- Founded
- INDO 2018
- RNXT 2012
- Country
- INDO Indonesia
- RNXT United States
- Employees
- INDO N/A
- RNXT N/A
- Industry
- INDO Oil & Gas Production
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- INDO Energy
- RNXT Health Care
- Exchange
- INDO Nasdaq
- RNXT Nasdaq
- Market Cap
- INDO 40.1M
- RNXT 34.0M
- IPO Year
- INDO 2019
- RNXT 2021
- Fundamental
- Price
- INDO $2.76
- RNXT $1.00
- Analyst Decision
- INDO
- RNXT Strong Buy
- Analyst Count
- INDO 0
- RNXT 2
- Target Price
- INDO N/A
- RNXT $6.00
- AVG Volume (30 Days)
- INDO 160.9K
- RNXT 72.3K
- Earning Date
- INDO 04-25-2025
- RNXT 05-09-2025
- Dividend Yield
- INDO N/A
- RNXT N/A
- EPS Growth
- INDO N/A
- RNXT N/A
- EPS
- INDO N/A
- RNXT N/A
- Revenue
- INDO $3,127,587.00
- RNXT $43,000.00
- Revenue This Year
- INDO N/A
- RNXT $690.69
- Revenue Next Year
- INDO N/A
- RNXT $4,006.81
- P/E Ratio
- INDO N/A
- RNXT N/A
- Revenue Growth
- INDO N/A
- RNXT N/A
- 52 Week Low
- INDO $2.06
- RNXT $0.77
- 52 Week High
- INDO $6.65
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- INDO 49.70
- RNXT 47.55
- Support Level
- INDO $2.65
- RNXT $0.97
- Resistance Level
- INDO $3.02
- RNXT $1.07
- Average True Range (ATR)
- INDO 0.17
- RNXT 0.07
- MACD
- INDO 0.01
- RNXT 0.01
- Stochastic Oscillator
- INDO 39.48
- RNXT 44.94
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.